World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
12845
World Ranking
4053
National Ranking
232

Overview

Jade Ghosn is affiliated with Hôpital Bichat - Claude-Bernard (Hôpitaux Universitaires Paris Nord Val de Seine) in France. Their research centers primarily on medicine, with a substantial focus on infectious diseases. Across their career, they have contributed significantly to subfields such as infectious diseases, virology, epidemiology, molecular biology, and neurology.

The scientist has authored numerous studies, with notable recent papers including:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19, 2020, Science
  • Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review, 2021, Clinical Microbiology and Infection
  • Mpox in people with advanced HIV infection: a global case series, 2023, The Lancet
  • A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations, 2020, Science Translational Medicine
  • Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort, 2021, Proceedings of the National Academy of Sciences

Ghosn's collaborative work includes frequent co-authorship with:

  • Diane Descamps (37 joint publications)
  • Yazdan Yazdanpanah (34 joint publications)
  • Quentin Le Hingrat (27 joint publications)
  • Valentine Marie Ferré (26 joint publications)
  • Gilles Peytavin (23 joint publications)

The scientist has published extensively in several journals, with recurring contributions to:

  • Journal of Antimicrobial Chemotherapy (14 publications)
  • Clinical Infectious Diseases (13 publications)
  • Médecine et Maladies Infectieuses Formation (11 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (8 publications)
  • Journal of Medical Virology (7 publications)

The main research topics of Jade Ghosn's work cover:

  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Poxvirus research and outbreaks
  • Herpesvirus Infections and Treatments

This profile reflects a focus on topics that merge clinical virology and infectious disease interventions, including emerging viral threats like SARS-CoV-2 and mpox in immunocompromised populations. The scientist's contributions span clinical research, vaccine efficacy, viral serology, and epidemiological modeling related to major infectious diseases.

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review.

    Thibault Fiolet;Yousra Kherabi;Conor-James MacDonald;Jade Ghosn

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

    Marc-Antoine Valantin;Camille Aubron-Olivier;Jade Ghosn;Elisabeth Laglenne

  • All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

    Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit

  • Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.

    Claudine Duvivier;Sami Kolta;Lambert Assoumou;Lambert Assoumou;Jade Ghosn

  • HIV

    Unknown

  • Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy

    Hassane Izzedine;Jean-Sebastien Hulot;Eric Villard;Catherine Goyenvalle

  • A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

    Ludivine Grzelak;Ludivine Grzelak;Sarah Temmam;Cyril Planchais;Caroline Demeret

  • Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.

    Nadège Néant;Guillaume Lingas;Quentin Le Hingrat;Jade Ghosn

  • Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection

    Abderaouf Damouche;Thierry Lazure;Véronique Avettand-Fènoël;Nicolas Huot

  • Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.

    Héloïse Flament;Héloïse Flament;Matthieu Rouland;Lucie Beaudoin;Amine Toubal

  • Omicron SARS-CoV-2 variant: What we know and what we don’t

    Unknown

  • Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

    Véronique Avettand-Fènoël;Véronique Avettand-Fènoël;Laurent Hocqueloux;Jade Ghosn;Antoine Cheret

  • Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.

    Jean-François Delfraissy;Philippe Flandre;Constance Delaugerre;Jade Ghosn

  • Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19.

    Unknown

  • Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.

    Unknown

  • Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA

    Moussa Laanani;Jade Ghosn;Asma Essat;Adeline Melard

  • Acute hepatitis C in HIV‐infected men who have sex with men

    J Ghosn;S Pierre‐François;Thibault;C Duvivier

  • HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.

    Jade Ghosn;Isabelle Pellegrin;Cécile Goujard;Christiane Deveau

  • Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

    Stéphanie Dominguez;Jade Ghosn;Marc-Antoine Valantin;Aurélie Schruniger

  • Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

    Jade Ghosn;Marie-Laure Chaix;Gilles Peytavin;Elisabeth Rey

  • Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?

    Amanda Mocroft;Peter Reiss;Ole Kirk

  • Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion

    Sara Lodi;Laurence Meyer;Anthony D. Kelleher;Magdalena Rosinska

  • Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.

    Jade Ghosn;Lionel Piroth;Olivier Epaulard;Paul Le Turnier

  • Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.

    Jade Ghosn;Jean-Paul Viard;Christine Katlama;Marta de Almeida

Frequent Co-Authors

Marie-Laure Chaix
Marie-Laure Chaix Université Paris Cité
Christine Rouzioux
Christine Rouzioux Necker-Enfants Malades Hospital
Christine Katlama
Christine Katlama Sorbonne University
Jean-François Delfraissy
Jean-François Delfraissy National Ethical Consultative Committee for Life Sciences and Health
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Jean-Paul Viard
Jean-Paul Viard Assistance Publique – Hôpitaux de Paris
Laurence Meyer
Laurence Meyer University of Paris-Saclay
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various interdisciplinary career paths, especially in the healthcare and information management sectors. For those interested in clinical applications, becoming a functional medicine nurse practitioner salary offers a promising avenue. This path blends microbiological knowledge with patient-centered treatment approaches.

Alternatively, with the increasing digitization of healthcare data, careers such as a certified professional coder (CPC) have become essential. Expertise in medical coding enhances the accuracy of health records and facilitates better healthcare delivery.

For those aiming higher, a master in health information management salary can provide leadership opportunities overseeing health data systems and improving organizational efficiencies.

To ensure quality and recognition, students should consider programs like an accredited online health information management degree CAHIIM. These programs offer flexible learning options while maintaining industry standards, aligning well with microbiology graduates seeking to expand their expertise.

Best Scientists Citing Jade Ghosn

Trending Scientists

Recently Published Articles